Clinical trial

Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma

NCT00359073 · University of Wisconsin, Madison, Other · Completed

Key facts

NCT number NCT00359073
Title Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma
Official title Effect of Montelukast on Experimentally-Induced RV16 Infection in Volunteers With Mild Asthma
Lead sponsor University of Wisconsin, Madison, Other
Status Completed
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions montelukast, placebo
Enrollment 25
Start date Oct 1, 2006
Primary completion Jan 1, 2009
Completion Jan 1, 2009
First posted Aug 1, 2006
Last update posted Mar 13, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies